Literature DB >> 4908342

Study of 1-adamantanamine hydrochloride used prophylactically during the Hong Kong influenza epidemic in the family environment.

A W Galbraith, J S Oxford, G C Schild, G I Watson.   

Abstract

1-Adamantanamine hydrochloride (aminoadamantane) has been shown to inhibit the multiplication of influenza A viruses in cell cultures, organ cultures and experimentally infected mice. An epidemic of influenza in Great Britain in the winter of 1967-68 provided the opportunity to study the prophylactic effect of aminoadamantane in the family environment and this paper reports the results of further observations in January-March 1969 during an influenza epidemic due to A2/Hong Kong/68.In a double-blind, placebo-controlled investigation of aminoadamantane given prophylactically, in doses of 100 mg every 12 hours for 10 days, no protective effect of the drug was demonstrated. In view of the positive effect of the drug in the earlier study during the winter of 1967-68, and the apparent sensitivity of the virus strain, an explanation involving the very high incidence of individuals possessing HI antibody of less than 1:12 is offered.

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 4908342      PMCID: PMC2427729     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  11 in total

1.  QUANTITATIVE HAEMADSORPTION, A NEW ASSAY TECHNIQUE. I. ASSAY OF INTERFERON.

Authors:  N B FINTER
Journal:  Virology       Date:  1964-12       Impact factor: 3.616

2.  Technique of complementfixation test applicable to the diagnosis of virus diseases.

Authors:  C M BRADSTREET; C E TAYLOR
Journal:  Mon Bull Minist Health Public Health Lab Serv       Date:  1962-05

3.  Inhibition of influenza viruses in vitro and in vivo by 1-adamantanamine hydrochloride.

Authors:  G C Schild; R N Sutton
Journal:  Br J Exp Pathol       Date:  1965-06

4.  Immunofluorescent studies on the inhibition of influenza A and B viruses in mammalian cell cultures by amines and ammonium compounds.

Authors:  J S Oxford; G C Schild
Journal:  J Gen Virol       Date:  1968-05       Impact factor: 3.891

5.  Studies on induced influenza in man. I. Double-blind studies designed to assess prophylactic efficacy of amantadine hydrochloride against a2/Rockville/1/65 strain.

Authors:  Y Togo; R B Hornick; A T Dawkins
Journal:  JAMA       Date:  1968-03-25       Impact factor: 56.272

6.  Studies on the antiviral activity of 1-adamantanamine.

Authors:  D A Tyrrell; M L Bynoe; B Hoorn
Journal:  Br J Exp Pathol       Date:  1965-08

7.  A field trial of amantadine prophylaxis in naturally-occurring acute respiratory illness.

Authors:  J F Finklea; A V Hennessy; F M Davenport
Journal:  Am J Epidemiol       Date:  1967-05       Impact factor: 4.897

8.  The suppression of A2 influenza in children by the chemoprophylactic use of Amantadine.

Authors:  J J Quilligan; M Hirayama; H D Baernstein
Journal:  J Pediatr       Date:  1966-10       Impact factor: 4.406

9.  THE IN VIVO ANTIVIRAL ACTIVITY OF 1-ADAMANTANAMINE (AMANTADINE). I. PROPHYLACTIC AND THERAPEUTIC ACTIVITY AGAINST INFLUENZA VIRUSES.

Authors:  R R GRUNERT; J W MCGAHEN; W L DAVIES
Journal:  Virology       Date:  1965-06       Impact factor: 3.616

10.  ANTIVIRAL ACTIVITY OF 1-ADAMANTANAMINE (AMANTADINE).

Authors:  W L DAVIES; R R GRUNERT; R F HAFF; J W MCGAHEN; E M NEUMAYER; M PAULSHOCK; J C WATTS; T R WOOD; E C HERMANN; C E HOFFMANN
Journal:  Science       Date:  1964-05-15       Impact factor: 47.728

View more
  19 in total

Review 1.  Perspectives on antiviral use during pandemic influenza.

Authors:  F G Hayden
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2001-12-29       Impact factor: 6.237

Review 2.  Amantadine and rimantadine for influenza A in adults.

Authors:  T Jefferson; V Demicheli; C Di Pietrantonj; D Rivetti
Journal:  Cochrane Database Syst Rev       Date:  2006-04-19

3.  Amantadine for influenza A.

Authors:  K G Nicholson; M J Wiselka
Journal:  BMJ       Date:  1991-02-23

4.  Post-exposure influenza prophylaxis with oseltamivir: cost effectiveness and cost utility in families in the UK.

Authors:  Beate Sander; Frederick G Hayden; Marlene Gyldmark; Louis P Garrison
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

5.  Pandemic flu: clinical management of patients with an influenza-like illness during an influenza pandemic. Provisional guidelines from the British Infection Society, British Thoracic Society, and Health Protection Agency in collaboration with the Department of Health.

Authors: 
Journal:  Thorax       Date:  2007-01       Impact factor: 9.139

6.  Editorial: Amantadine and influenza.

Authors: 
Journal:  Br Med J       Date:  1976-06-26

Review 7.  Antiviral agents: action and clinical use.

Authors:  T W Chang; D R Snydman
Journal:  Drugs       Date:  1979-11       Impact factor: 9.546

Review 8.  Antiviral chemotherapy: the first decade.

Authors:  D J Bauer
Journal:  Br Med J       Date:  1973-08-04

9.  Protection of man from natural infection with influenza A2 Hong Kong virus by amantadine: a controlled field trial.

Authors:  N Oker-Blom; T Hovi; P Leinikki; T Palosuo; R Pettersson; J Suni
Journal:  Br Med J       Date:  1970-09-19

10.  Recovery of drug-resistant influenza A virus during therapeutic use of rimantadine.

Authors:  F G Hayden; S J Sperber; R B Belshe; R D Clover; A J Hay; S Pyke
Journal:  Antimicrob Agents Chemother       Date:  1991-09       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.